Creative Planning’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-42,676
| Closed | -$193K | – | 4125 |
|
|
2025
Q4 | $193K | Sell |
42,676
-1,445
| -3% | -$7.4K | ﹤0.01% | 3567 |
|
|
2025
Q3 | $238K | Sell |
44,121
-2,977
| -6% | -$16.1K | ﹤0.01% | 3335 |
|
|
2025
Q2 | $256K | Sell |
47,098
-17,249
| -27% | -$68.4K | ﹤0.01% | 3034 |
|
|
2025
Q1 | $178K | Sell |
64,347
-19,714
| -23% | -$68.6K | ﹤0.01% | 3114 |
|
|
2024
Q4 | $287K | Buy |
84,061
+52,814
| +169% | +$152K | ﹤0.01% | 2703 |
|
|
2024
Q3 | $91.9K | Buy |
31,247
+3,212
| +11% | +$10.6K | ﹤0.01% | 3031 |
|
|
2024
Q2 | $95.3K | Buy |
28,035
+7,409
| +36% | +$24.2K | ﹤0.01% | 2845 |
|
|
2024
Q1 | $62.5K | Buy |
+20,626
| New | +$72.4K | ﹤0.01% | 2764 |
|
|
2023
Q3 | – | Sell |
-16,721
| Closed | -$174K | – | 2939 |
|
|
2023
Q2 | $174K | Buy |
+16,721
| New | +$150K | ﹤0.01% | 2247 |
|
|
2022
Q2 | – | Sell |
-12,139
| Closed | -$238K | – | 2332 |
|
|
2022
Q1 | $238K | Buy |
+12,139
| New | +$242K | ﹤0.01% | 1785 |
|
|
2021
Q2 | – | Sell |
-3,490
| Closed | -$319K | – | 2191 |
|
|
2021
Q1 | $319K | Buy |
3,490
+380
| +12% | +$36.9K | ﹤0.01% | 1761 |
|
|
2020
Q4 | $252K | Sell |
3,110
-1,493
| -32% | -$114K | ﹤0.01% | 1730 |
|
|
2020
Q3 | $214K | Buy |
+4,603
| New | +$257K | ﹤0.01% | 1634 |
|
Creative Planning's CVAC Position: Q1 2026 in Review
Creative Planning sold out of CureVac (CVAC) in Q1 2026, closing a stake of 42,676 shares — an estimated $193K sold.
Creative Planning first reported a position in CVAC in Q3 2020 and held it in 13 quarters. The position peaked at $319K in Q1 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Creative Planning reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Creative Planning sold 42,676 CureVac shares in Q1 2026, an estimated $193K.
- Creative Planning first reported a position in CureVac in Q3 2020 and held it in 13 quarters.
- Creative Planning's CureVac position peaked at $319K in Q1 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.